[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 43 of about 43
1. Tabatabai A, Hashemi M, Ahmadinejad M, Haghdani S, Sajjadi M, Mahzouni P, Hekmatnia A: Primary chest wall lymphoma with no history of tuberculous pyothorax: diagnosis and treatment. J Thorac Cardiovasc Surg; 2008 Dec;136(6):1472-5
MedlinePlus Health Information. consumer health - Lymphoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary chest wall lymphoma with no history of tuberculous pyothorax: diagnosis and treatment.
  • OBJECTIVE: Primary chest wall neoplasm represents only 5% of chest wall neoplasm and among them primary chest wall lymphoma is uncommon.
  • METHODS: A 28-year-old man had no history of tuberculous pyothorax or artificial pneumothorax therapy but did have a 4-month history of dyspnea, fever, chills, and night sweats.
  • On physical examination, a mass about 10 x 10 cm was noted on the anterior chest wall on the right side, and computed tomographic scan demonstrated that it originated from the pleural wall.
  • A 5 x 5-cm tender mass in the posterior wall of the left hemithorax was palpated.
  • Computed tomography showed mild plural effusion and erosion in the posterior segment of the left ninth rib.
  • RESULTS: With the diagnosis of large B cell lymphoma, chemotherapy was prescribed for the first patient, and the patient has been in complete remission for more than 5 months.
  • For the second patient, the left ninth rib along with the originated mass was completely resected and chemotherapy was prescribed.
  • CONCLUSION: Treatment of primary chest wall lymphoma was not clear and various treatment strategies were considered.
  • Remission of considerable duration in our patients leads us to suggest that surgery followed by adjuvant chemotherapy can provide a reasonable outcome in patients in whom the chest wall lymphoma is the only site of disease.
  • [MeSH-major] Lymphoma / diagnosis. Lymphoma / therapy. Soft Tissue Neoplasms / diagnosis. Soft Tissue Neoplasms / therapy
  • [MeSH-minor] Adult. Antineoplastic Agents / therapeutic use. Empyema, Tuberculous. Humans. Male. Ribs / surgery. Thoracic Wall / surgery. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19114192.001).
  • [ISSN] 1097-685X
  • [Journal-full-title] The Journal of thoracic and cardiovascular surgery
  • [ISO-abbreviation] J. Thorac. Cardiovasc. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


2. Witte B, Hürtgen M: Lymphomas presenting as chest wall tumors. Thorac Surg Sci; 2006;3:Doc01

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphomas presenting as chest wall tumors.
  • Four cases of thoracic lymphoma mimicking chest wall tumors are presented.
  • As resection is not the treatment of first choice in lymphomas, pretherapeutical evaluation of chest wall tumors should include a thoroughly staging and a biopsy for histopathological diagnosis.
  • Chest wall destruction due to an anterior mediastinal mass, or a chest wall tumor associated with mediastinal lymph node enlargement, could be suspicious of thoracic lymphoma.
  • Lymphoma with chest wall involvement mostly turns out to be Hodgkin's disease or large B-cell lymphoma.
  • Stage and histopathological diagnosis have major impact on treatment and prognosis.
  • Therapy is chemotherapy or chemo-radiation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiographics. 1999 May-Jun;19(3):617-37 [10336192.001]
  • [Cites] Clin Lab Haematol. 2000 Apr;22(2):127-8 [10792407.001]
  • [Cites] Leuk Lymphoma. 2000 Nov;39(5-6):531-41 [11342336.001]
  • [Cites] Kyobu Geka. 2004 Oct;57(11):1078-81 [15510827.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 May;19(5):584-8 [11343936.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 May;19(5):589-93 [11343937.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1374-81 [14630276.001]
  • [Cites] Leuk Lymphoma. 2003 Oct;44(10):1837-9 [14692546.001]
  • [Cites] Am J Clin Oncol. 2004 Jun;27(3):312-6 [15170155.001]
  • (PMID = 21289949.001).
  • [ISSN] 1862-4006
  • [Journal-full-title] Thoracic surgical science
  • [ISO-abbreviation] Thorac Surg Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC3011339
  • [Keywords] NOTNLM ; chest wall tumor / lymphoma / thoracic neoplasms
  •  go-up   go-down


3. Suarez CR, Bertolone SJ, Raj AB, Coventry S: Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm. Am J Hematol; 2004 May;76(1):52-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm.
  • Primitive neuroectodermal tumor of bone (PNET) is rarely observed as a SMN following treatment of childhood ALL.
  • The authors described the occurrence of a chest wall PNET of the bone at the site of a central line placement associated with both germ-line and tumor cell p53 mutation in a 8-year-old boy 1 year after completing therapy for standard risk ALL.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Neoplasms, Second Primary / genetics. Neuroectodermal Tumors, Primitive, Peripheral / genetics. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy. Thoracic Wall / pathology. Tumor Suppressor Protein p53 / genetics
  • [MeSH-minor] Child, Preschool. Combined Modality Therapy. Humans. Male. Mutation. Treatment Outcome

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia, Childhood.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2004 Wiley-Liss, Inc.
  • (PMID = 15114597.001).
  • [ISSN] 0361-8609
  • [Journal-full-title] American journal of hematology
  • [ISO-abbreviation] Am. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


Advertisement
4. Shimatani H, Furukawa K, Ebihara Y, Serizawa H, Tsuboi M, Ogata A, Konaka C, Kato H: An early stage diffuse B-cell lymphoma within a visible site of bronchofiberscope accompanied by peripheral lung cancer. Diagn Ther Endosc; 2000;6(4):179-82

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An early stage diffuse B-cell lymphoma within a visible site of bronchofiberscope accompanied by peripheral lung cancer.
  • We report a case of non-Hodgkin's lymphoma found at the orifice of right B2 accompanied by peripheral lung cancer in a 66-year-old asymptomatic man.
  • Chest X-ray films showed a mass shadow in the left lower lung field.
  • Simultaneously wall thickening at the orifice of the right B2 was found coincidentally.
  • The biopsy specimen from that site showed non-Hodgkin's lymphoma (diffuse B-cell type).
  • After left lower lobectomy, systemic chemotherapy was performed.
  • It is rare for malignant lymphoma to be recognized bronchofiberscopically.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18493536.001).
  • [ISSN] 1070-3608
  • [Journal-full-title] Diagnostic and therapeutic endoscopy
  • [ISO-abbreviation] Diagn Ther Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2362766
  •  go-up   go-down


5. Hsu PK, Hsu HS, Li AF, Wang LS, Huang BS, Huang MH, Hsu WH: Non-Hodgkin's lymphoma presenting as a large chest wall mass. Ann Thorac Surg; 2006 Apr;81(4):1214-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-Hodgkin's lymphoma presenting as a large chest wall mass.
  • BACKGROUND: Malignant lymphoma presenting as a solitary chest wall mass is not frequently seen.
  • The treatment for primary chest wall lymphoma remains unclear.
  • METHODS: From 1991 to 2004, of 157 patients with initial presentation of isolated chest wall mass, non-Hodgkin's lymphoma was diagnosed in 7 of them.
  • Patients with tumors arising from axillary lymph nodes or mediastinal lymphadenopathy with chest wall extension were excluded in the study.
  • Four of these 7 patients had the chest wall lymphoma as the only site of disease.
  • The pathologic diagnoses were malignant lymphoma in 2 patients and diffuse large B-cell lymphoma in 5 patients.
  • Three patients with chest wall lymphoma as the only site of disease had tumor excision followed by adjuvant chemotherapy.
  • The other patient with chest wall lymphoma as the only site of disease, who had chemotherapy as the initial treatment, remained free of disease for 6 months after treatment.
  • The other 3 patients with other organ involvement who were managed with chemotherapy with or without radiotherapy died of disease after a mean survival of 20 months.
  • CONCLUSIONS: Malignant lymphoma presenting as a large chest wall mass is not common.
  • Although the primary treatment of choice for lymphoma with or without chest wall involvement is chemotherapy, surgery followed by adjuvant chemotherapy can provide satisfactory outcome for some patients in whom the chest wall lymphoma was the only site of disease.
  • [MeSH-major] Lymphoma, Large B-Cell, Diffuse. Thoracic Neoplasms. Thoracic Wall

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Ann Thorac Surg. 2006 Apr;81(4):1218-9 [16564246.001]
  • (PMID = 16564245.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 30
  •  go-up   go-down


6. Ahmad I, Saeed U, Rehmani R, Ahmed ME: Primary bone lymphoma: a series from a cancer institute in Pakistan. J Pak Med Assoc; 2009 Mar;59(3):179-81
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary bone lymphoma: a series from a cancer institute in Pakistan.
  • Primary bone lymphoma (PBL) is an uncommon tumour.
  • All patients underwent chemotherapy with half receiving radiotherapy as their initial treatment.
  • All had diffuse large B-cell lymphoma (DLBCL) of bone except one (85 - M) who had chest wall cutaneous T-cell lymphoma with iliac blade involvement.
  • [MeSH-major] Bone Neoplasms / therapy. Lymphoma, Large B-Cell, Diffuse / therapy. Lymphoma, T-Cell, Cutaneous / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Drug Therapy. Female. Femur / pathology. Humans. Male. Middle Aged. Pakistan. Radiotherapy. Survival Rate. Thoracic Wall / pathology. Treatment Outcome

  • Genetic Alliance. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19288950.001).
  • [ISSN] 0030-9982
  • [Journal-full-title] JPMA. The Journal of the Pakistan Medical Association
  • [ISO-abbreviation] J Pak Med Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


7. Urushihata K, Koizumi T, Kaneki T, Yamaguchi S, Fujimoto K, Kubo K: Successful salvage therapy of irinotecan for relapsed Hodgkin's lymphoma. Intern Med; 2002 Aug;41(8):648-50
MedlinePlus Health Information. consumer health - Hodgkin Disease.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful salvage therapy of irinotecan for relapsed Hodgkin's lymphoma.
  • A 30-year-old man, who had a repeated history of relapsed Hodgkin's lymphoma over 7 years, developed bilateral pleural effusion and chest wall involvement.
  • This case demonstrated that irinotecan has a therapeutic effect in patients with relapsed Hodgkin's lymphoma.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Camptothecin / analogs & derivatives. Camptothecin / therapeutic use. Hodgkin Disease / drug therapy
  • [MeSH-minor] Adult. Enzyme Inhibitors / therapeutic use. Humans. Male. Recurrence. Salvage Therapy. Topoisomerase I Inhibitors

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12211535.001).
  • [ISSN] 0918-2918
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Enzyme Inhibitors; 0 / Topoisomerase I Inhibitors; 7673326042 / irinotecan; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


8. Miyashita T, Miyazawa I, Kawaguchi T, Kasai T, Yamaura T, Ito T, Takei M, Kiyosawa K: A case of primary cardiac B cell lymphoma associated with ventricular tachycardia, successfully treated with systemic chemotherapy and radiotherapy: a long-term survival case. Jpn Circ J; 2000 Feb;64(2):135-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of primary cardiac B cell lymphoma associated with ventricular tachycardia, successfully treated with systemic chemotherapy and radiotherapy: a long-term survival case.
  • We experienced a long-term survival case of primary cardiac lymphoma (PCL) demonstrating ventricular tachycardia (VT) as an initial sign, which was related to localized myocardial damage by lymphoma cells.
  • The origin of the VT was the free wall of the right ventricular outflow tract (RVOT) as observed by electrocardiography on admission.
  • A solitary mass in the free wall of the RVOT was found by echocardiography, chest computed tomographic scanning and magnetic resonance imaging.
  • Chemotherapy started immediately after the diagnosis and the mass showed a marked reduction in size.
  • After 8 cycles of chemotherapy, radiotherapy was performed.
  • Pericardial thickness in the free wall of the RVOT developed without severe side effects.
  • It was demonstrated that rapid diagnosis and chemotherapy followed by radiotherapy for PCL achieved better survival.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Heart Neoplasms. Lymphoma, B-Cell. Tachycardia, Ventricular

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10716528.001).
  • [ISSN] 0047-1828
  • [Journal-full-title] Japanese circulation journal
  • [ISO-abbreviation] Jpn. Circ. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] AUSTRALIA
  •  go-up   go-down


9. Niiyama S, Satoh K, Kaneko S, Aiba S, Takahashi M, Mukai H: Zosteriform skin involvement of nodal T-cell lymphoma: a review of the published work of cutaneous malignancies mimicking herpes zoster. J Dermatol; 2007 Jan;34(1):68-73
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Zosteriform skin involvement of nodal T-cell lymphoma: a review of the published work of cutaneous malignancies mimicking herpes zoster.
  • A 77-year-old Japanese woman initially presented with non-Hodgkin's lymphoma involving her neck, axillary and inguen lymph nodes.
  • She had edematous erythema and nodules limited to the skin in zosteriform distribution on the left side chest wall along the T4-5 dermatome.
  • It should be mentioned that 59% of the cases reported had been diagnosed with herpes zoster at the time of the initial examination and that many of them had received drug therapy (e.g. acyclovir).
  • [MeSH-major] Lymphoma, T-Cell, Cutaneous / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Cutaneous T-Cell Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17204106.001).
  • [ISSN] 0385-2407
  • [Journal-full-title] The Journal of dermatology
  • [ISO-abbreviation] J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 39
  •  go-up   go-down


10. Hsu PK, Hsu HS, Lee HC, Hsieh CC, Wu YC, Wang LS, Huang BS, Hsu WH, Huang MH: Management of primary chest wall tumors: 14 years' clinical experience. J Chin Med Assoc; 2006 Aug;69(8):377-82
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of primary chest wall tumors: 14 years' clinical experience.
  • BACKGROUND: Primary chest wall tumor is rare but it encompasses tumors of various origins.
  • We analyzed our experience with primary chest wall tumors with emphasis on its demographic presentation and management.
  • METHODS: From 1991 to 2004, 62 patients with the diagnosis of primary chest wall tumors were enrolled.
  • Lipoma, chest wall metastasis, direct invasion from nearby malignancy, infection, and inflammation of chest wall were excluded.
  • Chondrosarcoma and lymphoma were the 2 most common types of malignant chest wall tumors.
  • Nine of 31 patients (29.0%) with benign chest wall tumors were free of symptoms whereas patients with malignant chest wall tumors were all symptomatic (p = 0.002).
  • All patients with primary chest wall tumors, except 6 who had medical treatment only, underwent surgical resection.
  • Patients with malignant chest wall tumors were older than those with benign tumors (p < 0.001).
  • CONCLUSION: Patients with primary malignant chest wall neoplasm were older than those with benign tumors.
  • Adequate surgical resection remains the treatment of choice for patients with primary chest wall tumors.
  • For patients with isolated chest wall lymphoma, surgical resection followed by chemotherapy can be considered to obtain a better outcome.
  • [MeSH-major] Thoracic Neoplasms / therapy. Thoracic Wall

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16970274.001).
  • [ISSN] 1726-4901
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


11. Nishiyama N, Inoue K, Nakatani S, Hamba H, Kinoshita H: Malignant lymphoma presenting as a large mass in the anterior chest wall. Osaka City Med J; 2000 Dec;46(2):105-10
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant lymphoma presenting as a large mass in the anterior chest wall.
  • In general, the preferred treatment for malignant lymphoma is the cytotoxic chemotherapy.
  • However, the surgical intervention is often required for diagnosis and treatment in cases where the diagnosis is not obvious.
  • In well-chosen cases the surgical treatment can contribute importantly to a good outcome and quality of life even in malignant lymphoma.
  • We report a rare case of non-Hodgkin's lymphoma presenting as a large, rapidly growing mass in the anterior chest wall; resection was the key initial treatment.
  • [MeSH-major] Lymphoma, Non-Hodgkin / radiography. Lymphoma, Non-Hodgkin / surgery. Radiography, Thoracic. Thoracic Neoplasms / radiography. Thoracic Neoplasms / surgery. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11252729.001).
  • [ISSN] 0030-6096
  • [Journal-full-title] Osaka city medical journal
  • [ISO-abbreviation] Osaka City Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


12. Hodgson DC, Tsang RW, Pintilie M, Sun A, Wells W, Crump M, Gospodarowicz MK: Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy. Int J Radiat Oncol Biol Phys; 2003 Dec 1;57(5):1374-81
Hazardous Substances Data Bank. VINBLASTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
  • PURPOSE: To examine the impact of extranodal chest wall and lung invasion on the prognosis of patients with clinical Stage I-II Hodgkin's lymphoma treated with combined modality therapy.
  • MATERIALS AND METHODS: The outcome of 324 patients with clinical Stage I-II Hodgkin's lymphoma treated with combined modality therapy between 1981 and 1996 was analyzed.
  • Twenty-two patients had chest wall invasion and 40 had invasion of lung parenchyma.
  • The chemotherapy regimens used were ABVD in 182 patients (56%), MOPP/ABV(D) in 45 (14%), MOPP in 86 (27%), and other chemotherapy regimens in 11 patients (3%).
  • The impact of chest wall and lung invasion on local relapse, disease-free survival, cause-specific survival, and overall survival was examined.
  • Compared with patients with no extranodal involvement, patients with chest wall invasion had significantly worse local control (89% vs. 68%, p = 0.005), disease-free survival (84% vs. 59%, p = 0.016), and cause-specific survival (94% vs. 86%, p = 0.009).
  • Overall survival was also worse among patients with chest wall invasion, but not significantly so (90% vs. 82%, p = 0.10).
  • Among the 16 patients with chest wall invasion but without lung invasion, 7 progressed during treatment or relapsed, 6 with local failure (crude relapse rate 44%, 95% confidence interval [CI] 19-68%), and 5 died (crude death rate 31%, 95% CI 9-54%).
  • After adjusting for other significant prognostic factors, patients with chest wall invasion had significantly worse local control (hazard ratio 2.8, 95% CI 1.2-6.3), disease-free survival (hazard ratio 2.3, 95% CI 1.1-4.8), and cause-specific survival (hazard ratio 2.8, 95% CI 1.1-6.8).
  • CONCLUSIONS: Chest wall invasion is an adverse prognostic factor among clinical Stage I-II Hodgkin's lymphoma patients treated with combined modality therapy, although we did not find a worse outcome for patients with lung invasion.
  • Efforts to reduce treatment intensity in these patients should be undertaken with caution, recognizing their increased risk of local relapse.
  • [MeSH-major] Hodgkin Disease / pathology. Lung Neoplasms / pathology. Thoracic Wall / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Bleomycin / administration & dosage. Combined Modality Therapy. Dacarbazine / administration & dosage. Doxorubicin / administration & dosage. Female. Humans. Male. Mechlorethamine / administration & dosage. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Prednisone / administration & dosage. Procarbazine / administration & dosage. Radiotherapy / methods. Recurrence. Retrospective Studies. Survival Analysis. Vinblastine / administration & dosage. Vincristine / administration & dosage

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. NITROGEN MUSTARD N-OXIDE HYDROCHLORIDE .
  • Hazardous Substances Data Bank. DACARBAZINE .
  • Hazardous Substances Data Bank. MECHLORETHAMINE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. MECHLORETHAMINE HYDROCHLORIDE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • Hazardous Substances Data Bank. PROCARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14630276.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 11056-06-7 / Bleomycin; 35S93Y190K / Procarbazine; 50D9XSG0VR / Mechlorethamine; 5J49Q6B70F / Vincristine; 5V9KLZ54CY / Vinblastine; 7GR28W0FJI / Dacarbazine; 80168379AG / Doxorubicin; VB0R961HZT / Prednisone; ABVD protocol; MOPP protocol; VBA protocol
  •  go-up   go-down


13. MacLean FR, Hanley JP, Patton WN, Hart DN, Langley S, Bayston K, Jeffery GM: Successful high dose therapy for relapsed mediastinal large B cell lymphoma following surgical repair of anterior chest wall defect. Clin Lab Haematol; 2000 Apr;22(2):127-8
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful high dose therapy for relapsed mediastinal large B cell lymphoma following surgical repair of anterior chest wall defect.
  • We describe a man with relapsed large B cell mediastinal lymphoma and associated infected large anterior chest wall defect who required high dose salvage therapy for his underlying disease.
  • An initial mediastinotomy wound, associated with recurrent sepsis, had developed into an abscess, then fistula and eventually a large anterior chest wall defect.
  • Safe use of salvage chemotherapy required reconstructive surgery consisting of a pedicled muscle flap.
  • The subsequent high dose chemotherapy was carried out without complications and 15 months later the patient is alive and well.
  • [MeSH-major] Lymphoma, B-Cell / drug therapy. Lymphoma, Large B-Cell, Diffuse / drug therapy. Mediastinal Neoplasms / drug therapy. Reconstructive Surgical Procedures / methods. Salvage Therapy. Thoracic Surgical Procedures / methods. Thorax / microbiology
  • [MeSH-minor] Abscess / etiology. Abscess / surgery. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Dose-Response Relationship, Drug. Fistula / etiology. Fistula / surgery. Humans. Male. Middle Aged. Recurrence. Sepsis / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10792407.001).
  • [ISSN] 0141-9854
  • [Journal-full-title] Clinical and laboratory haematology
  • [ISO-abbreviation] Clin Lab Haematol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] ENGLAND
  •  go-up   go-down


14. Santini M, Fiorello A, Vicidomini G, Busiello L, Baldi A: A surgical case of pyothorax-associated lymphoma of T-cell origin arising from the chest wall in chronic empyema. Ann Thorac Surg; 2009 Aug;88(2):642-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A surgical case of pyothorax-associated lymphoma of T-cell origin arising from the chest wall in chronic empyema.
  • We report a surgical a case of pyothorax-associated lymphoma of T-cell origin arising from the chest wall and developing on pleural sequelae of therapeutic pneumothorax for pulmonary tuberculosis.
  • The chest wall defect repaired with a Marlex (Phillips Sumika Polypropylene Co, Houston, TX) prothesis.
  • The histologic, immunohistochemical, and genotypic features were conclusive for a diagnosis of T-cell non-Hodgkin lymphoma.
  • The patient received postoperative chemotherapy and is doing well after 15 months.
  • [MeSH-major] Empyema, Tuberculous / complications. Lymphoma, T-Cell / etiology. Thoracic Neoplasms / etiology. Thoracic Wall

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19632428.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


15. van den Berg H, van Rijn RR, Merks JH: Management of tumors of the chest wall in childhood: a review. J Pediatr Hematol Oncol; 2008 Mar;30(3):214-21
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of tumors of the chest wall in childhood: a review.
  • Chest wall tumors in childhood are major challenges with respect to diagnostic workup and treatment.
  • Depending on diagnosis, staging, and age, therapy has to be tailored for each patient, which should be discussed in a multidisciplinary team setting.
  • Radical resection is in most cases the major component of treatment.
  • Use of chemotherapy depends on the diagnosis.
  • In soft-tissue tumors, previously considered to be chemotherapy insensitive, favorable results are currently reported.
  • [MeSH-major] Lymphoma / therapy. Neuroblastoma / therapy. Rhabdomyosarcoma / therapy. Sarcoma, Ewing / therapy. Thoracic Neoplasms / therapy. Thoracic Wall / pathology
  • [MeSH-minor] Child. Combined Modality Therapy. Female. Humans. Male. Predictive Value of Tests

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18376284.001).
  • [ISSN] 1077-4114
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 63
  •  go-up   go-down


16. Bonini A, Tieghi A, Gamberi B, Imovilli A, Carbonelli C, Spaggiari L, Gugliotta L: Caspofungin for invasive aspergillosis: A single-centre prospective study. J Clin Oncol; 2009 May 20;27(15_suppl):e20618

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Caspofungin (Caspo) is the first drug able to inhibit the growth of the fungal cell wall.
  • METHODS: Since 2004 we began a prospective study with the administration of Caspo as first line therapy in 63 consecutive adult neutropenic pts.
  • With persistent fever despite antibiotics,a chest CT-scan and galactomannan test were performed.
  • The diagnoses were: leukemia 44, myeloma 3, lymphoma 16; the disease's phases were: new onset 24, remission 16, relapse 23.
  • 12 pts received an allogeneic and 6 an autologous transplant; the others received conventional chemotherapy.
  • BAL was performed in 37 pts.The mean time of treatment was 18 days.
  • Among pts submitted to an allogeneic HSCT the concomitant therapy with Cyclosporin A was not influenced by Caspo.
  • All surviving patients, upon discharge from the hospital, received oral treatment with voriconazole.
  • CONCLUSIONS: The resolution rate of the infections is very high; Caspo seems safe, it does not preclude any other treatment, it is well tolerated and the cost is lower than other antifungal treatments.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961616.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Spunt SL, Harper JA, Krasin MJ, Billups CA, Rodriguez-Galindo C: Ewing sarcoma family tumors (ESFT) as second malignant neoplasms (SMN) following treatment of a primary malignant neoplasm (PMN) during childhood. J Clin Oncol; 2004 Jul 15;22(14_suppl):8539

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ewing sarcoma family tumors (ESFT) as second malignant neoplasms (SMN) following treatment of a primary malignant neoplasm (PMN) during childhood.
  • Demographic data, diagnostic and treatment information for both the PMN and SMN, and outcome data were recorded.
  • The PMN was retinoblastoma (n=3), Wilms tumor (n=2), acute lymphoblastic leukemia, Hodgkin lymphoma, and non-Hodgkin lymphoma (n=1 each).
  • Six patients received chemotherapy for treatment of the PMN including alkylating agents (n=3), anthracyclines (n=6), and etoposide (n=1).
  • Four also received radiotherapy (RT) for the PMN (dose range, 10.8-48 Gy, median 30 Gy).
  • The ESFT primary sites were chest wall/rib (n=4), extremity (n=3) and pelvis (n=1).
  • CONCLUSIONS: The proportion of ESFT as a SMN following treatment of childhood cancer is similar to the proportion of ESFT as a PMN in childhood.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28013834.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Iwase S, Takahara S, Sekikawa T, Ito K, Nakada S, Yamazaki Y, Yamada J, Kobayashi M, Yamada H: [Disseminated MALT lymphoma associated with macroglobulinemia]. Rinsho Ketsueki; 2000 Nov;41(11):1183-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Disseminated MALT lymphoma associated with macroglobulinemia].
  • We report a case of disseminated MALT lymphoma with macroglobulinemia in an 80-year-old man who presented with a persistent fever.
  • A radiograph of the chest showed infiltration of the left lung and pleural effusion of the right lung.
  • A CT scan of the abdomen showed extensive thickening of the wall of the stomach adjacent to a peritoneal mass.
  • The final diagnosis was MALT lymphoma involving the stomach, lungs and bone marrow.
  • The patient did not consent to chemotherapy, and instead was given oral prednisolone.
  • [MeSH-major] Lymphoma, B-Cell, Marginal Zone / pathology. Waldenstrom Macroglobulinemia / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11193437.001).
  • [ISSN] 0485-1439
  • [Journal-full-title] [Rinshō ketsueki] The Japanese journal of clinical hematology
  • [ISO-abbreviation] Rinsho Ketsueki
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 13
  •  go-up   go-down


19. Koyama R, Hirayama Y, Nagai T, Ohta H, Kura T, Mogi Y, Kon S, Sakamaki S, Niitsu Y: A case of diffuse large B-cell lymphoma transformed from immunoglobulin A-producing marginal zone B-cell lymphoma. Int J Hematol; 2000 Oct;72(3):349-52
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of diffuse large B-cell lymphoma transformed from immunoglobulin A-producing marginal zone B-cell lymphoma.
  • We present a rare case of diffuse large B-cell lymphoma transformed from immunoglobulin (Ig) A-secreting marginal zone B-cell lymphoma.
  • Histological examination of the lymph node biopsy specimen revealed the appearance of marginal zone B-cell lymphoma.
  • The surface Ig of lymphoma cells was IgA-kappa, which coincided with the class of monoclonal Ig found in the patient's serum.
  • The lymph node swelling and pulmonary shadow subsided, and the serum IgA level was normalized by 3 courses of systemic chemotherapy.
  • However, after 4 courses of treatment, new tumor lesions at the right chest wall and left arm progressively became apparent.
  • The biopsy specimen of the tumor showed a feature of diffuse large B-cell lymphoma.
  • Despite intensive chemotherapy, the patient died of spreading tumor burden into the central nervous system.
  • [MeSH-major] Lymphoma, B-Cell / pathology. Lymphoma, B-Cell, Marginal Zone / pathology. Lymphoma, Large B-Cell, Diffuse / pathology
  • [MeSH-minor] Cell Transformation, Neoplastic. Female. Humans. Immunoglobulin A / immunology. Middle Aged. Neoplasms, Second Primary / pathology

  • Genetic Alliance. consumer health - Large B cell diffuse lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11185993.001).
  • [ISSN] 0925-5710
  • [Journal-full-title] International journal of hematology
  • [ISO-abbreviation] Int. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Immunoglobulin A
  •  go-up   go-down


20. Hirai S, Hamanaka Y, Mitsui N, Morifuji K, Sutoh M: Primary malignant lymphoma arising in the pleura without preceding long-standing pyothorax. Ann Thorac Cardiovasc Surg; 2004 Oct;10(5):297-300
Genetic Alliance. consumer health - Primary malignant lymphoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary malignant lymphoma arising in the pleura without preceding long-standing pyothorax.
  • We report a very rare case of primary malignant lymphoma arising in the pleura with no history of persistent pyothorax.
  • A 72-year-old male was hospitalized with dyspnea on effort and chest CT demonstrated a mass along the right chest wall.
  • Immunohistochemical examination of the pleural tumor showed that the histology was marginal zone B-cell malignant lymphoma.
  • We considered that this tumor had originated from the soft tissue in the chest wall based on radiographical and surgical findings.
  • As diagnosis and treatment of pleural malignant lymphoma seems to have been difficult in most cases reported in the literature, it is thought that early active and accurate biopsy with large-bore needles, or, if possible, surgical incision for early diagnosis and aggressive surgery to achieve complete resection combined with radiation therapy and/or chemotherapy would be very important for a good prognosis.
  • [MeSH-major] Lymphoma, B-Cell / complications. Lymphoma, B-Cell / diagnosis. Pleural Neoplasms / complications. Pleural Neoplasms / diagnosis
  • [MeSH-minor] Aged. Biopsy, Needle. Carcinoembryonic Antigen / blood. Combined Modality Therapy. Diagnosis, Differential. Dyspnea / etiology. Empyema, Pleural / etiology. Humans. Immunohistochemistry. Japan / epidemiology. Male. Prognosis. Rare Diseases. Thoracotomy. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15563266.001).
  • [ISSN] 1341-1098
  • [Journal-full-title] Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
  • [ISO-abbreviation] Ann Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen
  • [Number-of-references] 12
  •  go-up   go-down


21. Fajraoui N, Ben Hamida K, Hadj Kacem A, Amouri R, Ben Ghars K, Khiari I, Charfi MR: [Axonal neuropathy revealing pleural lymphoma as a long-term outcome of therapeutic pneumothorax]. Rev Med Interne; 2010 Aug;31(8):e3-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Axonal neuropathy revealing pleural lymphoma as a long-term outcome of therapeutic pneumothorax].
  • Peripheral neuropathy is a rare presenting feature of malignant lymphoma, and commonly associated with diagnostic delay.
  • We report a patient with axonal neuropathy revealing primary pleural lymphoma as a late outcome of pulmonary tuberculosis.
  • The patient complained of chest pain, altered general status.
  • Chest computed tomography (CT) showed pleural tumour invading the chest wall and CT-guided pleural biopsy revealed a B-cell lymphoma.
  • Chemotherapy was not started in consideration of the poor performance status of the patient.
  • Despite corticosteroids, the peripheral neuropathy worsened and the patient died 2 months after the diagnosis of lymphoma.
  • To our knowledge, no previous case of peripheral neuropathy revealing pleural lymphoma has been reported.
  • The diagnosis of lymphoma must be entertained in the presence of peripheral neuropathy of unknown aetiology.
  • Neuropathy associated to lymphoma results from various mechanisms and is characterised by clinical polymorphism.
  • Their prognosis depends on the mechanism of the neuropathy and the severity of the lymphoma.

  • MedlinePlus Health Information. consumer health - Peripheral Nerve Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010. Published by Elsevier SAS.
  • (PMID = 20416988.001).
  • [ISSN] 1768-3122
  • [Journal-full-title] La Revue de medecine interne
  • [ISO-abbreviation] Rev Med Interne
  • [Language] FRE
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


22. Nishiyama N, Nakatani S, Inoue K, Katoh T, Kinoshita H: Primary lymphoma of bone originating in a rib. Jpn J Thorac Cardiovasc Surg; 2000 Mar;48(3):180-3
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary lymphoma of bone originating in a rib.
  • Malignant lymphoma originating in the bone is rare and is now recognized as being an independent clinicopathologic entity known as primary lymphoma of bone.
  • A 60-year-old man complaining of right chest and back pain consulted our hospital for further examination.
  • Chest X-ray and computed tomogram revealed osteolysis and a surrounding soft tissue mass in the sixth right rib.
  • A diagnosis of diffuse, medium-sized non-Hodgkin's lymphoma, B-cell type was made.
  • En block resection of the tumor and chest wall was performed.
  • Unfortunately, postoperative treatment with radiation therapy and chemotherapy was ultimately unsuccessful, and a local recurrence and metastatic lesions appeared in the stomach and para-aortic abdominal lymph nodes 7 months after the first symptom appeared.
  • Surgery was chosen as the initial therapy as it was considered that a rib resection would not result in serious respiratory compromise and the complete resection of the tumor would be superior to radiation therapy for local control.
  • Some authors have reported that the surgical resection of a primary lymphoma of the bone originating in a rib can yield a good prognosis.
  • However, it is a systemic disease and a more effective therapeutic strategy should be developed.
  • [MeSH-major] Bone Neoplasms / surgery. Lymphoma, B-Cell / surgery. Lymphoma, Non-Hodgkin / surgery. Ribs

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10793497.001).
  • [ISSN] 1344-4964
  • [Journal-full-title] The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai zasshi
  • [ISO-abbreviation] Jpn. J. Thorac. Cardiovasc. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] JAPAN
  •  go-up   go-down


23. Hasegawa Y, Shirai S, Mishina T, Nakata M, Aikawa K, Yoshida K: [An elderly non-Hodgkin lymphoma patient with a massive tumor of the heart]. Rinsho Ketsueki; 2002 Jul;43(7):538-42
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An elderly non-Hodgkin lymphoma patient with a massive tumor of the heart].
  • We report on an elderly patient with a malignant lymphoma forming a huge mass in the heart.
  • A hypodermical mass in the right frontal chest was detected.
  • She was diagnosed as having non-Hodgkin lymphoma, diffuse large cell type, B-cell type.
  • Computed tomography scans showed a markedly thickened right ventricular wall of the heart, swollen lymph nodes of the mediastinum, bilateral pleural effusions, and a tumor in the spleen.
  • Lymphoma cells were found in the pleural effusion, and the lymphoma was diagnosed as clinical stage IV.
  • EF increased to 70% after 3 courses of chemotherapy with CHOP regimen.
  • All lesions disappeared after 6 courses of chemotherapy were completed.
  • After consolidative radiotherapy with a total dose of 37 Gy to the mediastinum and heart, bilateral pleural effusions, elevation of the patient's lactate dehydrogenase level and soluble IL-2 receptor value were recognized, which suggested relapse of the lymphoma, although histopathological confirmation could not be realized.
  • [MeSH-major] Heart Neoplasms / therapy. Lymphoma, B-Cell / therapy. Lymphoma, Large B-Cell, Diffuse / therapy

  • Genetic Alliance. consumer health - Heart tumor.
  • Genetic Alliance. consumer health - Hodgkin lymphoma.
  • Genetic Alliance. consumer health - Non-Hodgkin Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12229122.001).
  • [ISSN] 0485-1439
  • [Journal-full-title] [Rinshō ketsueki] The Japanese journal of clinical hematology
  • [ISO-abbreviation] Rinsho Ketsueki
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


24. Chajari M, Lacroix J, Peny AM, Chesnay E, Batalla A, Henry-Amar M, Delcambre C, Génot JY, Fruchard C, Bardet S: Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography? Eur J Nucl Med Mol Imaging; 2002 Mar;29(3):380-7
Hazardous Substances Data Bank. GALLIUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
  • The usefulness and complementarity of gallium (67Ga) scintigraphy and computed tomography (CT) in the management of patients with lymphoma have been extensively demonstrated.
  • As fusion imaging techniques between single-photon emission tomography (SPET) and CT have been developed recently, we investigated whether use of CT/67Ga SPET fusion imaging could help in the interpretation of 67Ga scintigraphy.
  • From November 1999 to May 2001, 52 consecutive fusion studies were performed in 38 patients [22 patients with Hodgkin's disease (HD) and 16 patients with non-Hodgkin's lymphoma (NHL)] as part of pre-treatment staging (n=13), treatment evaluation (n=20) or evaluation of suspected recurrence (n=19).
  • On day 2, 67Ga SPET and CT were performed, focussing on the chest and/or the abdomen/pelvis.
  • Image fusion was considered to be of benefit in 12/52 (23%) studies which were performed for initial staging (n=4), treatment evaluation (n=4) or evaluation of suspected recurrence (n=4).
  • In these cases, image fusion allowed either confirmation and/or localisation of pathological gallium uptake (n=10) or detection of lesions not visible on CT scan (n=2).
  • In the abdomen and pelvis, fusion helped to differentiate physiological bowel elimination from abnormal uptake, and assisted in precisely locating uptake in neighbouring viscera of the left hypochondrium, including the spleen, left liver lobe, coeliac area, stomach wall and even the splenic flexure.
  • Clinical management was altered by fusion imaging in one patient (chemotherapy was given instead of radiotherapy) and was potentially affected in three other patients (in that, in conjunction with other factors, the results of fusion imaging had an influence on the decision regarding use of irradiation and especially the treatment volume).
  • CT/67Ga SPET fusion therefore appears valuable in facilitating the interpretation of 67Ga scintigraphy and we recommend its use in patients with lymphoma when CT and 67Ga scintigraphy are planned.
  • [MeSH-major] Citrates. Gallium. Hodgkin Disease / radionuclide imaging. Lymphoma, Non-Hodgkin / radionuclide imaging. Tomography, Emission-Computed / methods. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12002715.001).
  • [ISSN] 1619-7070
  • [Journal-full-title] European journal of nuclear medicine and molecular imaging
  • [ISO-abbreviation] Eur. J. Nucl. Med. Mol. Imaging
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Citrates; 0 / Radiopharmaceuticals; 27905-02-8 / gallium citrate; CH46OC8YV4 / Gallium
  •  go-up   go-down


25. Nakagawa H: [A case of primary cardiac lymphoma complicated by idiopathic thrombocytopenic purpura]. Nihon Kokyuki Gakkai Zasshi; 2002 Mar;40(3):265-9
Genetic Alliance. consumer health - Idiopathic thrombocytopenic purpura.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of primary cardiac lymphoma complicated by idiopathic thrombocytopenic purpura].
  • A computed tomography (CT) scan of the chest revealed a tumor mass in the right anterior ventricular wall.
  • The cytology of the pleural effusion was consistent with non-Hodgkin's lymphoma.
  • Primary cardiac lymphoma (PCL) was diagnosed.
  • The tumor mass showed a marked reduction in size after 3 cycles of chemotherapy, but thrombocytopenia unrelated to bone marrow failure appeared.
  • Idiopathic thrombocytopenic purpura (ITP) was suspected and prednisolone therapy was begun, and ultimately brought about a partial remission.
  • Autoimmune disorders are occasionally associated with malignant lymphoma.
  • [MeSH-major] Heart Neoplasms / complications. Lymphoma, Non-Hodgkin / complications. Purpura, Thrombocytopenic, Idiopathic / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11974905.001).
  • [ISSN] 1343-3490
  • [Journal-full-title] Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
  • [ISO-abbreviation] Nihon Kokyuki Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


26. Kim YB, Chang SK, Yang WI, Hahn JS, Koom WS, Shim SJ, Park W, Lee KK, Suh CO, Kim GE: Primary NK/T cell lymphoma of the testis. A case report and review of the literature. Acta Haematol; 2003;109(2):95-100
Hazardous Substances Data Bank. METHOTREXATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary NK/T cell lymphoma of the testis. A case report and review of the literature.
  • We report a case of aggressive 'nasal type' natural killer (NK)/T cell lymphoma initially presenting as a testicular tumor in a Korean man, which quickly took a fatal course by widespread dissemination.
  • Immunophenotyping by immunohistochemistry yielded surface markers consistent with NK/T cell lymphoma.
  • During involved-field irradiation and chemotherapy following radical orchiectomy, the tumor disseminated shortly to the skin and soft tissue of his anterior chest wall and central nervous system (CNS).
  • To the best of our knowledge, this is the 9th reported case of confirmed NK/T cell lymphoma arising from the testis.
  • Relevant literature is reviewed, and the clinicopathologic features, natural history, and treatment options for primary testicular NK/T cell lymphoma are discussed.
  • [MeSH-major] Killer Cells, Natural. Lymphoma, T-Cell / diagnosis. Testicular Neoplasms / diagnosis
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Central Nervous System / pathology. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Fatal Outcome. Herpesvirus 4, Human / genetics. Humans. Immunohistochemistry. Immunophenotyping. In Situ Hybridization. Male. Methotrexate / therapeutic use. Middle Aged. Necrosis. Neoplasm Metastasis. Orchiectomy. Prednisone / therapeutic use. RNA, Viral / analysis. Radiotherapy. Recurrence. Skin / pathology. Thoracic Wall / pathology. Tomography, X-Ray Computed. Ultrasonography. Vincristine / therapeutic use

  • MedlinePlus Health Information. consumer health - Testicular Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2003 S. Karger AG, Basel
  • (PMID = 12624494.001).
  • [ISSN] 0001-5792
  • [Journal-full-title] Acta haematologica
  • [ISO-abbreviation] Acta Haematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / RNA, Viral; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; YL5FZ2Y5U1 / Methotrexate; CHOP protocol
  • [Number-of-references] 16
  •  go-up   go-down


27. Chrissos D, Kalmantis T, Belegrati M, Katsaros A, Tapanlis E, Katsimichas A, Triantafillou G, Kallikazaros I: One-year follow-up of a patient with reversible tricuspid valve stenosis due to lymphomatic mass into the right atrioventricular wall. Echocardiography; 2002 Oct;19(7 Pt 1):565-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] One-year follow-up of a patient with reversible tricuspid valve stenosis due to lymphomatic mass into the right atrioventricular wall.
  • We present the case of a 66-year-old man with a history of coronary artery disease and chronic lymphocytic leukemia (CLL) who was admitted to the hospital complaining of chest discomfort and shortness of breath on exertion.
  • The echocardiogram revealed a severe pericardial effusion and a large echogenic mass that infiltrated the lateral wall of the right atrium and ventricle and created a moderate tricuspid valve stenosis.
  • B cell intracardiac non-Hodgkin lymphoma/CLL was diagnosed, and the patient was treated with six courses of CHOP chemotherapy.
  • [MeSH-minor] Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Follow-Up Studies. Humans. Male. Prednisone / therapeutic use. Time Factors. Treatment Outcome. Vincristine / therapeutic use

  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12376008.001).
  • [ISSN] 0742-2822
  • [Journal-full-title] Echocardiography (Mount Kisco, N.Y.)
  • [ISO-abbreviation] Echocardiography
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


28. Welcker K, Nakashima M, Diemel KD, Welker L, Galle J, Merz H, Branscheid D: Pyothorax-associated lymphoma (PAL): report and review of a rare entity. Thorac Surg Sci; 2004;1:Doc03
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pyothorax-associated lymphoma (PAL): report and review of a rare entity.
  • Pyothorax-associated lymphoma (PAL) is a rare haematological malignancy often associated with artificial pneumothorax due to the treatment of pulmonary tuberculosis.
  • After clinical examination and imaging processes a chest wall tumour anterior on the right side was diagnosed as well as a persisting pyothorax.
  • A diagnosis of a high grade B-cell lymphoma was established after histological examination of the surgical biopsy.
  • Additional gastric involvement of B-cell lymphoma could be diagnosed by gastroscopy because of postoperative gastrointestinal bleeding.
  • The patient received chemotherapy with 2 courses of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP).
  • The response was favourable initially, but 2 months later the patient died because of lymphoma progression.Most cases of PAL have been described by Japanese investigators and only a few cases are reported in Western countries.
  • To the best of our knowledge this case of PAL is the first to be documented in Germany.Awareness of this rare entity, together with diligent histological examination, in patients with chronic pyothorax are essential for a correct diagnosis and correct early treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur Respir J. 1998 Mar;11(3):779-83 [9596137.001]
  • [Cites] J Pathol. 1997 Nov;183(3):287-92 [9422983.001]
  • [Cites] Ann Oncol. 1997 Nov;8(11):1133-8 [9426333.001]
  • [Cites] Thorax. 1996 Jan;51(1):103-4 [8658356.001]
  • [Cites] Rev Med Interne. 1999 Nov;20(11):985-91 [10586437.001]
  • [Cites] Mol Pathol. 2001 Apr;54(2):80-5 [11322168.001]
  • [Cites] Am J Surg Pathol. 2002 Jun;26(6):724-32 [12023576.001]
  • [Cites] Curr Opin Pulm Med. 2002 Jul;8(4):317-22 [12055396.001]
  • [Cites] J Clin Oncol. 2002 Oct 15;20(20):4255-60 [12377970.001]
  • [Cites] Clin Imaging. 2003 May-Jun;27(3):162-5 [12727052.001]
  • [Cites] Histopathology. 2004 Jan;44(1):69-76 [14717672.001]
  • [Cites] Mod Pathol. 1994 Dec;7(9):906-11 [7892158.001]
  • [Cites] Am J Pathol. 1993 Oct;143(4):1044-9 [8214001.001]
  • [Cites] Am J Surg Pathol. 1996 Jun;20(6):760-6 [8651357.001]
  • (PMID = 21289975.001).
  • [ISSN] 1862-4006
  • [Journal-full-title] Thoracic surgical science
  • [ISO-abbreviation] Thorac Surg Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC3011363
  • [Keywords] NOTNLM ; B cell lymphoma / B-Zell-Lymphom / Empyem / Pyothorax-assoziiertes Lymphom (PAL) / Tuberkulose / artificial pneumothorax / artifizielle Pneumothorax / empyema / pyothorax-associated lymphoma / tuberculosis
  •  go-up   go-down


29. Berk V, Yildiz R, Akdemir UO, Akyurek N, Karabacak NI, Coskun U, Benekli M: Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging. Clin Nucl Med; 2008 May;33(5):365-6
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.
  • A 49-year-old man presented with a left nasal cavity mass, biopsy of which revealed extranodal NK/T cell lymphoma.
  • A PET-CT scan showed increased F-18 FDG uptake in the nasal mass, anterior mediastinal lymph nodes, and multiple subcutaneous nodular deposits in the chest wall, gluteal region, and right femoral areas.
  • The patient achieved complete remission with salvage l-asparaginase therapy after failing first-line standard anthracycline-based chemotherapy.
  • [MeSH-major] Fluorodeoxyglucose F18. Lymphoma, Extranodal NK-T-Cell / radionuclide imaging. Nose Neoplasms / radionuclide imaging. Positron-Emission Tomography / methods. Skin Neoplasms / radionuclide imaging

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18431160.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


30. Hashizume T, Fujimoto H: [Pyothorax associated lymphoma with increased neuron-specific enolase level in serum and pleural effusion: a case report]. Kekkaku; 2004 May;79(5):361-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pyothorax associated lymphoma with increased neuron-specific enolase level in serum and pleural effusion: a case report].
  • The computed tomography image showed a tumor mass arising from the wall of chronic pyothorax.
  • The tumor was resected including the wall of the chronic pyothrax and right chest wall with several ribs.
  • The tumor was 7.2 x 7.0 x 3.0 cm in size and the pathological diagnosis was non-Hodgkin's lymphoma diffuse large cell, B-cell type.
  • Postoperative chemotherapy and radiation therapy were performed but he died of recurrence and metastasis of the tumor 5 months later after the operation.
  • [MeSH-major] Biomarkers, Tumor / analysis. Empyema, Pleural / complications. Lymphoma, B-Cell / etiology. Lymphoma, Large B-Cell, Diffuse / etiology. Phosphopyruvate Hydratase / analysis. Pleural Effusion / enzymology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15211877.001).
  • [ISSN] 0022-9776
  • [Journal-full-title] Kekkaku : [Tuberculosis]
  • [ISO-abbreviation] Kekkaku
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 4.2.1.11 / Phosphopyruvate Hydratase
  •  go-up   go-down


31. Hirose Y, Masaki Y, Okada J, Kim CG, Kawabata H, Ogawa N, Wano Y, Sugai S: Epstein-Barr virus-associated B-cell type non-Hodgkin's lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate. Int J Hematol; 2002 May;75(4):412-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epstein-Barr virus-associated B-cell type non-Hodgkin's lymphoma with concurrent p53 protein expression in a rheumatoid arthritis patient treated with methotrexate.
  • A Japanese male patient received various medications for his long-standing rheumatoid arthritis (stage IV, class II).
  • He developed a mass on the right anterior chest wall after being treated with methotrexate (MTX) for 4 months.
  • A biopsy of the mass showed it to be Epstein Barr virus (EBV)-associated lymphoma of B-cell phenotype stage IE (bulky mass), with positive EBV-encoded small RNAs (EBERs) in situ hybridization, EBV latent membrane protein-1 (LMP-1) negative, EB nuclear antigen-2 (ERNA-2) negative, CD20/L26 (+), CD45RO/UCHL-1 (-).
  • With discontinuation of MTX and administration of chemotherapy, the tumor disappeared but recurred after 3 months.
  • [MeSH-major] Arthritis, Rheumatoid / complications. Epstein-Barr Virus Infections / complications. Immunosuppressive Agents / adverse effects. Lymphoma, B-Cell / virology. Methotrexate / adverse effects. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Arthritis.
  • Genetic Alliance. consumer health - Rheumatoid arthritis.
  • MedlinePlus Health Information. consumer health - Rheumatoid Arthritis.
  • Hazardous Substances Data Bank. METHOTREXATE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1991 Dec 1;68(11):2460-5 [1657357.001]
  • [Cites] Am J Clin Pathol. 2000 Feb;113(2):212-8 [10664623.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5455-9 [8390666.001]
  • [Cites] N Engl J Med. 1993 May 6;328(18):1317-21 [8385742.001]
  • [Cites] Arthritis Rheum. 1995 Jun;38(6):867-8 [7779133.001]
  • [Cites] Lancet. 1984 Mar 17;1(8377):583-7 [6142304.001]
  • [Cites] J Virol. 1996 Jul;70(7):4849-53 [8676521.001]
  • [Cites] Transplantation. 1996 Sep 27;62(6):869-72 [8824493.001]
  • [Cites] Arthritis Rheum. 1999 Aug;42(8):1773-6 [10446880.001]
  • [Cites] Arthritis Rheum. 1996 Feb;39(2):325-9 [8849387.001]
  • [Cites] J Rheumatol. 1995 Jun;22(6):1174-8 [7674250.001]
  • [Cites] Hum Pathol. 2000 Feb;31(2):253-5 [10685644.001]
  • [Cites] J Rheumatol. 2001 Jan;28(1):47-53 [11196542.001]
  • [Cites] J Rheumatol. 1997 Oct;24(10):2035-7 [9330950.001]
  • (PMID = 12041674.001).
  • [ISSN] 0925-5710
  • [Journal-full-title] International journal of hematology
  • [ISO-abbreviation] Int. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Immunosuppressive Agents; 0 / Tumor Suppressor Protein p53; YL5FZ2Y5U1 / Methotrexate
  •  go-up   go-down


32. Ishii E, Honda K, Nakagawa A, Urago K, Oshima K: Primary CD30/Ki-1 positive anaplastic large cell lymphoma of skeletal muscle with der(17)t(1;17)(q11;p11). Cancer Genet Cytogenet; 2000 Oct 15;122(2):116-20
Genetic Alliance. consumer health - Lymphoma, large-cell.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary CD30/Ki-1 positive anaplastic large cell lymphoma of skeletal muscle with der(17)t(1;17)(q11;p11).
  • CD30/Ki-1 positive anaplastic large cell lymphoma (Ki-1 ALCL) frequently exhibits extranodal disease and chromosomal t(2;5)(p23;q35).
  • Tumors of the chest wall, left arm and leg, hepatomegaly, pleural effusion, and enlarged lymph nodes then developed.
  • She received seven cycles of intensive chemotherapy followed by an autologous peripheral blood stem cell transplantation, and has been in complete remission for more than two years.
  • The primary involvement of skeletal muscle is quite uncommon in ALCL, and an abnormal karyotype including t(1;17)(q11;p11) has not been reported previously.
  • [MeSH-major] Chromosomes, Human, Pair 1 / genetics. Chromosomes, Human, Pair 17 / genetics. Lymphoma, Large-Cell, Anaplastic / genetics. Muscle Neoplasms / genetics. Muscle, Skeletal / pathology. Translocation, Genetic

  • Genetic Alliance. consumer health - Anaplastic Large Cell Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11106821.001).
  • [ISSN] 0165-4608
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] UNITED STATES
  •  go-up   go-down


33. Hernández Allende R, Banzo I, Quirce R, Pena FJ, Carril JM: [Scintigraphic image in a case of atypical presentation of Burkitt lymphoma. The role of the scintigraphy with 67Ga SPECT in the diagnosis and post-treatment control]. Rev Esp Med Nucl; 2004 Mar-Apr;23(2):119-23

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Scintigraphic image in a case of atypical presentation of Burkitt lymphoma. The role of the scintigraphy with 67Ga SPECT in the diagnosis and post-treatment control].
  • We present a case of Burkitt's disease with bone (thoracic wall, femur) and lymph node involvement.
  • The patient had symptoms of fever with thoracic wall and femur pain.
  • A chest X-ray showed rib abnormalities.
  • 99mTc-DPD scan showed thoracic wall (one rib) and femur involvement.
  • 67Gallium SPECT showed thoracic wall (one rib more) and abdominal lymph node involvement that was not detected by planar images.
  • After 6 chemotherapy sessions a new 67gallium scan and CT scan were performed.
  • 67Gallium SPECT showed involvement in the thoracic wall (one rib) that was not detected in planar images.
  • [MeSH-major] Burkitt Lymphoma / radionuclide imaging. Gallium Radioisotopes. Tomography, Emission-Computed, Single-Photon

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15000943.001).
  • [ISSN] 0212-6982
  • [Journal-full-title] Revista española de medicina nuclear
  • [ISO-abbreviation] Rev Esp Med Nucl
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Gallium Radioisotopes
  •  go-up   go-down


34. Chung KM, Chuang SS, Hwang WS, Lee PS, Li CY: High dose chemotherapy and allogenic peripheral blood stem cell transplantation for multiple myeloma evolving from intra-abdominal plasmacytoma. Zhonghua Yi Xue Za Zhi (Taipei); 2002 Nov;65(11):557-60
Hazardous Substances Data Bank. PREDNISOLONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High dose chemotherapy and allogenic peripheral blood stem cell transplantation for multiple myeloma evolving from intra-abdominal plasmacytoma.
  • We present an unusual case of intra-abdominal plasmacytoma in a young woman which was misdiagnosed and treated as T cell lymphoma initially.
  • High dose chemotherapy followed by allogeneic peripheral stem cell blood transplantation (allo-PBSCT) was given.
  • The patient was well and alive without evidence of disease 4 years after wide excision of the recurrence of chest wall solitary plasmacytoma and local radiotherapy.
  • [MeSH-major] Abdominal Neoplasms / complications. Hematopoietic Stem Cell Transplantation. Multiple Myeloma / therapy. Plasmacytoma / complications
  • [MeSH-minor] Adult. Combined Modality Therapy. Female. Humans. Melphalan / administration & dosage. Prednisolone / administration & dosage. Transplantation, Homologous

  • Genetic Alliance. consumer health - Multiple myeloma.
  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Multiple Myeloma.
  • Hazardous Substances Data Bank. MELPHALAN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12583522.001).
  • [ISSN] 0578-1337
  • [Journal-full-title] Zhonghua yi xue za zhi = Chinese medical journal; Free China ed
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi (Taipei)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 9PHQ9Y1OLM / Prednisolone; Q41OR9510P / Melphalan
  •  go-up   go-down


35. Falleti J, Giordano M, Cozzolino I, Vetrani A, De Renzo A, Zeppa P: Cutaneous needle track seeding of mesothelioma diagnosed by fine needle aspiration cytology: a case report. Acta Cytol; 2010 Sep-Oct;54(5 Suppl):811-4
MedlinePlus Health Information. consumer health - Mesothelioma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Diagnostic and therapeutic procedures for mesothelioma require surgical biopsy or the usage of different-sized needles.
  • Thoracic wall involvement along the surgical or needle tracks has been reported.
  • CASE: A 57-year-old woman who had suffered from non-Hodgkin's lymphoma complained of dyspnea and left pleural effusion.
  • The patient had been treated with chemotherapy and radiotherapy and was in remission since then.
  • Within 2 weeks from thoracentesis, the patient complained of an erythematous swelling in her left chest wall, in the area of the needle track.
  • A diagnosis of chest wall involvement from mesothelioma was established and histologically confirmed.
  • CONCLUSION: Chest wall infiltration is a definite risk in the management of pleural mesothelioma, and FNAC is a useful procedure for a timely diagnosis of this ominous complication.
  • [MeSH-major] Mesothelioma / diagnosis. Mesothelioma / pathology. Skin / pathology. Thoracic Wall / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21053546.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Zwick M, Shih WJ, Greenwood M, Cibull ML, Miller S: Resolution of Ga-67 citrate uptake in the left neck mass of Hodgkin's disease and reversion of double scoliosis of cervical-thoracic and lower lumbar vertebrae. Ann Nucl Med; 2000 Aug;14(4):299-301
Hazardous Substances Data Bank. GALLIUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 6-yr-old boy underwent a total body Ga-67 citrate imaging study because of a large mass of Hodgkin's lymphoma in the left neck and the left anterior chest wall region.
  • The images showed intense uptake in the left neck extending anteroinferiorly to the left upper chest wall corresponding to the left neck and chest region.
  • After three cycles of chemotherapy, in the follow-up Ga-67 citrate total body images seven months after his first Ga-67 citrate imaging, the intense uptake in the left neck and the left upper chest wall had been resolved and the scoliosis of the cervical-thoracic and lower lumbar spine had also been reversed to normal.
  • This case shows that a Ga-67 citrate imaging study is useful for first diagnosis and subsequent monitoring of the therapeutic effects in a follow-up imaging.
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Child. Humans. Male. Scoliosis / drug therapy. Scoliosis / radionuclide imaging

  • Genetic Alliance. consumer health - Scoliosis.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11023031.001).
  • [ISSN] 0914-7187
  • [Journal-full-title] Annals of nuclear medicine
  • [ISO-abbreviation] Ann Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] JAPAN
  • [Chemical-registry-number] 0 / Citrates; 0 / Gallium Radioisotopes; 27905-02-8 / gallium citrate; CH46OC8YV4 / Gallium
  •  go-up   go-down


37. McAfee SL, Powell SN, Colby C, Spitzer TR: Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy. Int J Radiat Oncol Biol Phys; 2002 May 1;53(1):151-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To evaluate the feasibility of dose escalation of total body irradiation (TBI) above the previously reported maximally tolerated dose, we have undertaken a Phase I-II trial of dose-escalated TBI with autologous peripheral blood stem cell transplantation (PBSCT) for chemotherapy-refractory lymphoma.
  • METHODS AND MATERIALS: Nine lymphoma patients with primary refractory disease (PRD) or in resistant relapse (RR) received dose-escalated TBI and PBSCT.
  • Lung blocks were used to reduce the TBI transmission dose by 50%, and the chest wall dose was supplemented to the prescribed dose using electrons.
  • Three patients, two with non-Hodgkin's lymphoma (NHL) in RR and one with PRD Hodgkin's disease, received 1,600 cGy + PBSCT, three patients (two NHL in RR, one PRD) received 1,800 cGy + PBSCT, and three patients with NHL (two in RR, one PRD) received 2,000 cGy + PBSCT.
  • Interstitial pneumonitis developed in 1 patient who received 1,800 cGy after receiving recombinant alpha-interferon (with exacerbation after rechallenge with interferon).
  • CONCLUSION: TBI in a dose range 1,600-2,000 cGy as preparative therapy for autologous PBSCT is feasible and has substantial activity in chemorefractory non-Hodgkin's and Hodgkin's lymphoma.
  • [MeSH-major] Hematopoietic Stem Cell Transplantation. Hodgkin Disease / therapy. Lymphoma, Non-Hodgkin / therapy. Whole-Body Irradiation / adverse effects
  • [MeSH-minor] Adult. Combined Modality Therapy. Dose Fractionation. Feasibility Studies. Female. Humans. Male. Middle Aged. Pilot Projects. Transplantation, Autologous

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12007954.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Latz D, Alfrink M, Nassar N, Beyerle C: Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation. Onkologie; 2004 Oct;27(5):477-9
MedlinePlus Health Information. consumer health - Male Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation.
  • BACKGROUND: With increasing numbers of patients subjected to total body irradiation and bone marrow transplantation for treatment of several systemic malignancies more and more patients with second malignancies were observed.
  • CASE REPORT: We report the case of a 29- year-old man who developed breast cancer 13 years after treatment for acute lymphoblastic leukemia.
  • Therapy for leukemia included total body irradiation (TBI) and bone marrow transplantation (BMT).
  • Breast cancer was treated with mastectomy and irradiation of the left chest wall.
  • 17 months later the patient developed malignant pleural effusion and died despite chemotherapy and hormonal therapy due to further tumor progression.
  • [MeSH-major] Bone Marrow Transplantation / adverse effects. Breast Neoplasms, Male / diagnosis. Breast Neoplasms, Male / etiology. Neoplasms, Radiation-Induced / etiology. Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy. Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery. Whole-Body Irradiation / adverse effects


39. Farris AB 3rd, Kradin RL: Follicular localization of dendritic cells in a xanthomatous inflammatory tumor of lung associated with human herpes virus-8 infection. Virchows Arch; 2006 Dec;449(6):726-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 17-year-old man was treated with chemotherapy and radiation for nodular sclerosing Hodgkin lymphoma that presented as a left chest wall mass.
  • [MeSH-minor] Activin Receptors, Type II / analysis. Adolescent. Antigens, CD1 / analysis. Humans. Male

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 2002 Jul;41(1):1-29 [12121233.001]
  • [Cites] Am J Surg Pathol. 1992 Mar;16(3):276-81 [1309172.001]
  • [Cites] Am J Surg Pathol. 1991 Dec;15(12):1181-7 [1720931.001]
  • [Cites] Am J Surg Pathol. 2002 Aug;26(8):1089-91; author reply 1091-2 [12170101.001]
  • [Cites] Lab Invest. 2000 Jul;80(7):1121-6 [10908158.001]
  • [Cites] Am J Surg Pathol. 1994 Oct;18(10):1065-8 [8092397.001]
  • [Cites] Am J Surg Pathol. 2001 May;25(5):624-9 [11342774.001]
  • [Cites] Histopathology. 2005 Jun;46(6):604-13 [15910591.001]
  • [Cites] Chest. 1987 Oct;92 (4):756-7 [3652767.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1990;416(4):281-6 [2106746.001]
  • (PMID = 17106709.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD1; 0 / CD1a antigen; EC 2.7.11.30 / ACVRL1 protein, human; EC 2.7.11.30 / Activin Receptors, Type II
  •  go-up   go-down


40. Kadota Y, Utsumi T, Inoue M, Sawabata N, Minami M, Okumura M: Radiation-induced osteosarcoma 17 years after mediastinal irradiation following surgical removal of thymoma. Gen Thorac Cardiovasc Surg; 2010 Dec;58(12):651-3
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Radiation-induced osteosarcoma is a rare complication after irradiation of primary malignancies.
  • In the chest wall, it is usually secondary to radiotherapy for breast cancer or lymphoma.
  • A 49-year-old woman presented with a sternal tumor 17 years after surgery plus mediastinal irradiation (50 Gy) for a stage III thymoma.
  • Despite intensive combination chemotherapy that initially stabilized her disease, the patient died 2 years after the diagnosis was made.
  • [MeSH-major] Bone Neoplasms / etiology. Neoplasms, Radiation-Induced / etiology. Osteosarcoma / etiology. Sternum / radiation effects. Thymectomy. Thymoma / therapy. Thymus Neoplasms / therapy
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Biopsy. Fatal Outcome. Female. Humans. Middle Aged. Radiotherapy, Adjuvant / adverse effects. Time Factors. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Osteosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Thymus Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2006 Sep;450:76-81 [16906097.001]
  • [Cites] J Clin Oncol. 1999 Apr;17(4):1164 [10561175.001]
  • [Cites] Ann Surg Oncol. 1996 Jul;3(4):387-92 [8790852.001]
  • [Cites] J Thorac Cardiovasc Surg. 2008 Dec;136(6):1481-5 [19114194.001]
  • [Cites] Cancer. 1998 Jan 1;82(1):8-34 [9428476.001]
  • [Cites] J Clin Oncol. 2003 May 15;21(10):2011-8 [12743156.001]
  • [Cites] J Chemother. 2001 Jun;13(3):324-30 [11450892.001]
  • [Cites] Breast J. 2002 Sep-Oct;8(5):320-2 [12199765.001]
  • [Cites] Cancer. 2002 Feb 1;94(3):624-32 [11857293.001]
  • (PMID = 21170638.001).
  • [ISSN] 1863-6713
  • [Journal-full-title] General thoracic and cardiovascular surgery
  • [ISO-abbreviation] Gen Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


41. Chi DS, Abu-Rustum NR, Sonoda Y, Chen SW, Flores RM, Downey R, Aghajanian C, Barakat RR: The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol; 2004 Aug;94(2):307-11
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 2-cm chest wall incision was made in the fifth intercostal space on the side of the effusion.
  • After VATS, all patients had a chest tube placed through the incision, and those with malignant effusions underwent talc pleurodesis either intraoperatively or postoperatively.
  • Median operative time for VATS was 31 min (range: 20-49 min) with no complications attributable to the procedure.
  • Final diagnosis of primary disease site was as follows: ovary, 9 (75%); fallopian tube, 1 (8%); endometrium, 1 (8%); and lymphoma, 1 (8%).
  • Based on the findings during VATS, laparotomy and attempted cytoreduction were avoided in four patients (33%), and the cytoreductive procedure was modified in one patient (8%).
  • VATS should be considered in these cases to delineate the extent of disease, treat the effusion, and to potentially select patients for either intrathoracic cytoreduction or a neoadjuvant chemotherapy approach.

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15297166.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Jain S, Nigam S, Kumar N, Reddy BS: Cutaneous relapse in Hodgkin's disease: a case report. Acta Cytol; 2005 Mar-Apr;49(2):191-4
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE: A young male presented with multiple nodular lesions on the chest wall and matted cervical lymph nodes.
  • The cytologic diagnosis of Hodgkin's lymphoma was entertained and later confirmed on skin biopsy.
  • Past history revealed that the patient had been diagnosed with Hodgkin's disease and treated for it 2 years earlier, but had been lost to follow-up during treatment.
  • CONCLUSION: Cutaneous Hodgkin's disease should always be considered in smears from skin lesions showing atypical mononuclear cells in a polymorphous background, even in the absence of a definitive clinical diagnosis at the time of presentation.
  • [MeSH-minor] Adult. Biopsy, Needle. Disease Progression. Drug Therapy. Humans. Leukocytes, Mononuclear / pathology. Lymph Nodes / pathology. Male. Prognosis. Recurrence

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15839627.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


43. Yu ZY, Yang G, Ouyang XN, Yao LQ: [T-cell primary chest wall anaplastic large cell lymphoma--a case report]. Zhonghua Yi Xue Za Zhi; 2005 Jun 22;85(23):1656
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [T-cell primary chest wall anaplastic large cell lymphoma--a case report].
  • [MeSH-major] Lymphoma, Large-Cell, Anaplastic / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adolescent. Antigens, CD30 / analysis. Antineoplastic Agents / therapeutic use. Female. Humans. Lymphoma, T-Cell / drug therapy. Lymphoma, T-Cell / metabolism. Lymphoma, T-Cell / pathology. Protein-Tyrosine Kinases / analysis. Receptor Protein-Tyrosine Kinases. Thoracic Wall

  • Genetic Alliance. consumer health - Anaplastic Large Cell Lymphoma.
  • Genetic Alliance. consumer health - Lymphoma, large-cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16185543.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD30; 0 / Antineoplastic Agents; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / anaplastic lymphoma kinase
  •  go-up   go-down






Advertisement